Gapping up
In reaction to strong earnings/guidance: LAYN +5.2%, PBY +4.1%, PLAB +3.2% (light volume), HWAY +3.0% (also announces medicare health support settlement with the centers for medicare and medicaid services), BMO +2.4%, AZO +1.9% (light volume), SYK +0.7% (reaffirms FY10 EPS of $3.27-3.30; also announces definitive agreement to sell OP-1 for use in orthopaedic bone applications to Olympus for $60 mln).
M&A news: GAS +6.4% (NICOR and AGL Resources to combine in $8.6 bln transaction; Nicor shareholders to receive cash and stock valued at $53.00 per share).
Select financial related names showing strength: AIB +13.5% and IRE +11.1% (Ireland rolls out its austerity plans to comply with the EU's Irish aid package), FITB +2.5%, PNC +2.4%, C +2.3%, HBAN +2.3%, HIG +2.1%, UBS +2.0%, ING +2.0%.
Select metals/mining stocks seeing continued strength: URG +5.8%, SHZ +5.3%, EXK +4.0%, RIO +3.4%, MT +3.3%, NG +3.3%, REE +3.1%, BHP +3.1%, HL +3.0%, URRE +3.0%, PAL +2.8%, SLW +2.7%, FCX +2.5%, TCK +2.5%.
Select oil/gas related names showing strength: REP +3.9%, CRZO +3.7%, STO +2.2%, EOG +2.1%, APC +2.1%, E +2.0%, WFT +1.9%, TOT +1.9%, RDS.A +1.8%.
Select solar names trading higher: TSL +3.1%, LDK +1.7%, FSLR +0.8%.
Other news: SPPI +10.5% (reports single dose ZEVALIN in first-ever Phase 2 monotherapy trial for non-Hodgkin's lymphoma shows significant and durable clinical responses; also reports ZEVALIN demonstrates 35-month progression-free survival benefit after single dose in patients with non-Hodgkin's lymphoma), CYTK +5.2% (continuing to climb following yesterday's late surge higher), UL +4.0% (climbed higher overseas following yesterday's upgrade), JBL +4.0% and WY +2.3% (Cramer makes positive comments on MadMoney), ARO +3.6% (still checking), ABB +3.4% (traded higher overseas), AIXG +2.9% (still checking), AKS +2.8% (Steel Announces Pricing of $150 Million Senior Notes Offering), NOK +2.7% (still checking), STEM +2.6% (receives authorization to conduct world's first neural stem cell trial in spinal cord injury), CYTX +1.5% (enters strategic equity deal with Astellas Pharma to sell $10 mln in equity at $7.00/share), NOR +0.9% (prices 10 mln shares of common stock at $11.35 ), WLP +0.6% (Cramer makes positive comments on MadMoney), .
Analyst comments: WDC +2.2% (initiated with Buy at Citigroup), NVS +1.8% (upgraded to Outperform from Neutral at Credit Suisse), HGSI +1.5% (initiated with an Outperform at Credit Suisse), LDK +1.5% (initiated with Market Perform at Wells Fargo), DG +1.0% (upgraded to Buy from Hold at Think Equity), GSK +0.6% (upgraded to Neutral from Underperform at Credit Suisse).